# Azeria Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/azeria-therapeutics

- Industry: Biotechnology
- Headquarters: Cambridge, UK
- Website: www.azeriatherapeutics.com
- Total disclosed funding: $14M
- Latest round: Series B (Nov 8, 2019)
- Investors on record: 2

## About

Azeria Therapeutics Limited is a biotechnology company focused on developing innovative therapies for rare diseases, leveraging cutting-edge research to improve patient outcomes.Founded in 2017 in Cambridge, UK, Azeria Therapeutics Limited specializes in creating therapeutic solutions for rare genetic conditions. The company raised GBP 7 million in Series B funding in November 2019, led by Syncona Partners with participation from Sixth Element Capital. With two total deals, the company aims to advance its research and product development initiatives.Azeria Therapeutics Limited focuses on developing novel therapies for rare diseases, addressing unmet medical needs through proprietary drug discovery and development processes. The company's innovative approach targets specific genetic mutations, offering tailored treatments that aim to enhance patient care and outcomes.Azeria Therapeutics Limited's revenue generation strategy is centered around securing funding through investment rounds, specifically the most recent Series B funding of GBP 7 million. This capital is intended to support ongoing research and development efforts focused on their therapeutic pipeline.In the near future, Azeria Therapeutics Limited plans to launch new therapeutic products aimed at treating rare genetic disorders, with strategic timelines for market entry based on research progress. The company aims to expand its reach into North America and Europe by 2025, capitalizing on recent funding from their Series B round to enhance research capabilities and accelerate product development.

## Funding rounds

- Series B, Nov 8, 2019, $9M — Syncona, Sixth Element Capital
- Series A, Mar 23, 2018, $4.9M — Sixth Element Capital

## Investors

- Sixth Element Capital (https://capitalatlas.ai/funds/sixth-element-capital) — Series A, Series B
- Syncona (https://capitalatlas.ai/funds/syncona) — Series B